Search

Displaying results 8271 - 8280 of 10000 in total
  1. Drug

    DU125530

    go.drugbank.com/drugs/DB16040
    Investigational

    DU125530 is under investigation in clinical trial NCT01119430 (Fluoxetine Versus Fluoxetine Plus DU125530 in Major Depressive Disorder).

  2. Drug

    GP2 peptide

    go.drugbank.com/drugs/DB16180
    Investigational

    GP2 peptide is under investigation in clinical trial NCT00524277 (Vaccine Therapy in Treating Patients With Breast Cancer).

  3. Drug

    Mureletecan

    go.drugbank.com/drugs/DB15020
    Investigational

    Mureletecan is under investigation in clinical trial NCT00004076 (PNU 166148 in Treating Patients With Metastatic Solid Tumors).

  4. Drug

    Hydrogen

    go.drugbank.com/drugs/DB15127
    Investigational

    Hydrogen is under investigation in clinical trial NCT02830854 (Molecular Hydrogen for Cognitive Function and Performance in Elderly).

  5. Drug

    Futuximab

    go.drugbank.com/drugs/DB15262
    Investigational

    Futuximab is under investigation in clinical trial NCT01955473 (Japanese Phase 1 Trial of Sym004 in Solid Tumors).

  6. Drug

    Epalrestat

    go.drugbank.com/drugs/DB15293
    Investigational

    Epalrestat is under investigation in clinical trial NCT03244358 (Evaluation of Epalrestat in Metastatic Triple-negative Breast Cancer).

  7. Drug

    Simmerafil

    go.drugbank.com/drugs/DB22792
    Investigational

    Simmerafil is under investigation in clinical trial NCT06301854 (Long-term Safety of TPN171H Tablet in Erectile Dysfunction.).

  8. Drug

    Sudapyridine

    go.drugbank.com/drugs/DB18984
    Investigational

    Sudapyridine is under investigation in clinical trial NCT05824871 (Sudapyridine (WX-081) in Rr/mdr/xdr-tuberculosis Patients).

  9. Drug

    SY-12321

    go.drugbank.com/drugs/DB33922
    Experimental

    SY-12321 is a small molecule drug. SY-12321 is under investigation in clinical trial NCT07810933 (A Phase 1/2 Study of SY-12321 in Patients With ALK-positive Advanced Malignancies).

  10. Drug

    Tifenazoxide

    go.drugbank.com/drugs/DB21402
    Investigational

    Tifenazoxide is a small molecule drug. Tifenazoxide is under investigation in clinical trial NCT04744129 (Headache Inducing Effect of NN414 in Migraine Patients).